ホーム › がん（全種類） › ニューヨーク › New York City
New York City、NYにおけるがん（全種類）の臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する109件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
PediRISE Feasibility
被験者募集中
- Columbia University Medical Center, New York
Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
A Study of ASP3082 in Adults With Advanced Solid Tumors
被験者募集中第1相
- Columbia University - Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center, New York
Registry Study for Radiation Therapy Outcomes
被験者募集中観察研究
- New York Proton Center, New York
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
被験者募集中観察研究
- NYU Grossman School of Medicine, New York
A Study of Music Therapy for Anxiety in People With Cancer
被験者募集中
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
被験者募集中第3相
- Investigative Site, New York
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center, New York
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
被験者募集中第2相
- Rockefeller Outpatient Pavilion ( Site 0002), New York
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
被験者募集中第1相
- NYU Langone Health, New York
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center ( Site 4010), New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
被験者募集中観察研究
- NYU Langone Medical Center, New York
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- Icahn School of Medicine at Mount Sinai, New York
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- NYU Langone Medical Center, New York
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
被験者募集中
- Columbia University Irving Medical Center, New York
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Manhattan Eye, Ear, and Throat Hospital, New York
- Staten Island University Hospital, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Prospective Study to Assess a Diagnostic Aid for Cancer
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
被験者募集中観察研究
- City College of New York (Data Collection AND Data Analysis), New York
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
- Memorial Sloan Kettering Cancer Center, New York
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- New York University - Langone Medical Center - The Center for Musculoskeletal Care, New York
- Weill Cornell Medicine / New York Presbyterian Hospital, New York
- Icahn School Of Medicine At Mount Sinai, New York
- 他2件
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center ( Site 3010), New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
被験者募集中第2相
- NYU Langone Health, New York
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
被験者募集中第1/2相
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- 他1件
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- Icahn School of Medicine at Mount Sinai, New York
Psychotherapy Intervention for Latinos With Advanced Cancer
被験者募集中健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
- Ralph Lauren Center for Cancer Care and Prevention, New York
Psychotherapy Intervention for Latinos With Adv Cancer
被験者募集中健康なボランティア歓迎
- MSK at Ralph Lauren, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Laura and Isaac Perlmutter Cancer Center, New York
- Manhattan Eye, Ear and Throat Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
被験者募集中第2相
- Laura and Isaac Perlmutter Cancer Center, New York
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
被験者募集中観察研究
- Mount Sinai Hospital, New York
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
被験者募集中第3相
- Manhattan Hematology /Oncology Associates, New York
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C (NY), New York
Lurbinectedin in FET-Fused Tumors
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
被験者募集中観察研究健康なボランティア歓迎
- Weill Cornell Medical College (Data or Specimen Analysis Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
A Study of ARC-02 in B-cell NHL
被験者募集中第1相
- NYU Langone, New York
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai Hospital, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- 他2件
A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
Abatacept in Immune Checkpoint Inhibitor Myocarditis
被験者募集中第3相
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
被験者募集中健康なボランティア歓迎
- NYP/Weill Cornell Medical Center, New York
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
被験者募集中
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
被験者募集中第4相
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Mount Sinai Chelsea, New York
- Bellevue Hospital Center, New York
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- 他3件
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
被験者募集中第1相健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
A Study of ASP1002 in Adults for Treatment of Solid Tumors
被験者募集中第1相
- Icahn School of Medicine at Mount Sinai, New York
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)
被験者募集中健康なボランティア歓迎
- Columbia University Irving Medical Center, New York
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
被験者募集中第1/2相
- Mount Sinai - The Tisch Cancer Institute /ID# 272470, New York
- Weill Cornell Medical College /ID# 272517, New York
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
被験者募集中第1相
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- NYU Langone Health-Perlmutter Cancer Center, New York
- Memorial Sloan Kettering Cancer Center - Melanoma & Immunotherapeutics, New York
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第1相
- Mt Sinai /ID# 251166, New York
- Memorial Sloan Kettering Cancer Center-Koch Center /ID# 251167, New York
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
被験者募集中第1相
- Local Institution - 0011, New York
- Memorial Sloan Kettering Cancer Center, New York
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
被験者募集中第1相
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
被験者募集中第2相
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Evaluation of Grief Therapy Approaches for Bereaved Parents
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- New York University Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
被験者募集中第1相
- GSK Investigational Site, New York
A Multi Center Study of Sexual Toxicities After Radiotherapy
被験者募集中観察研究
- Icahn School of Medicine at Mount Sinai, New York
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- Memorial-Sloan Kettering Cancer Center, New York
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- VA NY Harbor Healthcare System, New York, NY, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- NYU Langone Medical Center, New York
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
被験者募集中第1/2相
- Weill Medical College of Cornell University, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, New York
- Research Site, New York
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
被験者募集中第1相
- NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
被験者募集中第1/2相
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
被験者募集中第1/2相
- Lenox Hill Brain Tumor Center, New York
A Study of Herbal Supplements in Cancer Survivors With Constipation
被験者募集中
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- Laura and Isaac Perlmutter Cancer Center / NYU Langone Health, New York
- Columbia University Medical Center, New York
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
被験者募集中第2相
- Perlmutter Cancer Center - 34th Street, New York
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
被験者募集中第2相
- Weill Cornell Medicine, New York
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
被験者募集中第1相
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Columbia University Medical Center, New York
- Memorial Slone Kettering Cancer Center, New York
A New Psychotherapy Intervention for Older Cancer Patients
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
被験者募集中
- The New York Proton Center, New York
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
被験者募集中観察研究
- Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment Center, New York
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Universal Genetic Testing for Cancer Risk Reduction
被験者募集中健康なボランティア歓迎
- NYU Langone Health, New York
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
被験者募集中第1/2相
- Columbia University Irving Medical Center, New York
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers
被験者募集中
- NYU Langone Health, New York
Food and Microbiome Longitudinal Investigation (FAMiLI)
被験者募集中観察研究健康なボランティア歓迎
- New York University School of Medicine, New York
Primary Tumor Research and Outcomes Network
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
GEMINI-NSCLC: NSCLC Biomarker Study
被験者募集中観察研究
- Icahn School of Medicine at Mount Sinai, New York
Upright MRI for Prostate Cancer Screening
被験者募集中観察研究
- Icahn School of Medicine at Mount Sinai, New York
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
被験者募集中第1相
- Ichan School of Medicine at Mount Sinai, New York
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
Cryopreservation of Ovarian Tissue
被験者募集中
- Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
An Acupuncture Study for Cancer Survivors With Joint Pain
被験者募集中健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
被験者募集中
- Columbia University Medical Center, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- NYU Langone Health, New York
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Weill Cornell Medicine-New York-Presbyterian Hospital, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
被験者募集中観察研究
- Icahn School of Medicine at Mount Sinai, New York
Personalized Models for Cancer Research
被験者募集中観察研究健康なボランティア歓迎
- New York Stem Cell Foundation Research Institute, New York
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
被験者募集中第1/2相
- NYU Langone Health, New York
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Durham, NC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- Arlington, VA48件の研究
- St. Louis, MO46件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
- 心不全51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。